CTI BioPharma Corp. [NASDAQ:CTIC] is seeing significant action in the Healthcare space. CTIC stock has price per sales of 79.30. The company is also booking -0.70 earnings per share.
The tape is active for CTI BioPharma Corp. [CTIC] and the current price target sits at $4.67.
To add more color to this price target, CTIC’s high over the last year is $6.00 and the low is $4.00. Over the last two 52 weeks, the company is trading 287.56%, while the S&P 500 is trading 1.71%.
The Bears are coming
Holding a Market Cap of $182.39 million, CTI BioPharma Corp. has seen a trading range over the last year of $0.62-$3.68.
For the last five days, CTIC is up from its last closing price. The average shares trading hands each day is 3.52M.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for CTIC. When we apply the Elder Force Index to CTI BioPharma Corp., we are seeing an Elder Force Indicator number of -304392.1.
In the last quarter, CTIC made a profit of 10.0 million. CTI BioPharma Corp. also saw quarter revenue growth year over year of -87.28%.
Looking at popular technical indicators, the company’s 5-day moving average is 2.96 compared to the 50-day moving average of 0.48%. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. CTIC currently holds a 9-day RSI of 81.24%, while 100-day RSI stands at 64.25%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. CTIC’s 9-day MACD is 0.88 and the company’s 100-day MACD stands at 1.80.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 0.39% by insiders and 46.25% by institutions.
Overall, the recommended rating for CTIC is Moderate Buy. Currently, the company has 3 analysts watching the stock, and the average quarterly earnings estimate is -0.15.
To review, the current 1-year target estimate is sitting at 4.67, while the current price 2.99. Based on this, we expect the stock to rise considering the aforementioned fundamentals.